‘Concordance’ not top priority in pharmaceutical care? Newsletter Article 12 February 2013 Pages: 3 - 3
Lessons for community-based disease prevention programmes Newsletter Article 12 February 2013 Pages: 3 - 3
Will managed care improve the care for patients with schizophrenia? Newsletter Article 12 February 2013 Pages: 4 - 4
Vinorelbine better value than taxanes in breast cancer Newsletter Article 12 February 2013 Pages: 5 - 5
Big increase in UK asthma drug spend needed for optimal control Newsletter Article 12 February 2013 Pages: 6 - 6
Cost effectiveness of platelet glycoprotein IIb/IIIa inhibitors Newsletter Article 12 February 2013 Pages: 9 - 9
Primary nosocomial bloodstream infections increase ICU costs Newsletter Article 12 February 2013 Pages: 10 - 10